Clinical Trials in Arizona

Showing 6381-6400 of 16,770 trials

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NCT03664960

This is a Phase 2, open-label, extension study to assess the safety and tolerability of AK002, given monthly for up to 26 doses.

Eosinophilic GastritisEosinophilic GastroenteritisEosinophilic Duodenitis

Allakos Inc.58 participantsStarted Nov 2018

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Ventura, California, United States +14 more locations

WITHDRAWN35 miles

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

NCT04294030

This study is designed to compare the performance of the NOWDx HSV-2 Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. The NOWDx HSV-2 Test is intended for qualitatively detecting the presence or absence of human Immunoglobulin G (IgG) class antibodies to HSV-2 in human whole blood to aid in the diagnosis of infection caused by herpes simplex virus type 2 (HSV-2).

HSV-2 InfectionHerpes Simplex Virus Infection

NOWDiagnostics, Inc.Started Mar 2023

Tempe, Arizona, United States • Coral Gables, Florida, United States • Lexington, Kentucky, United States

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Find Trials by Condition in Arizona

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

OCS Lung System EXPAND II Trial

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

Strategic Timing of Antiretroviral Treatment

ACS Community Access to Resources Education and Support

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors